Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jan 19;17(4):474–486. doi: 10.1080/15476286.2019.1708549

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.

PMC Copyright notice

Figure 2. — Expression levels of three RNMTs (FTSJ3, NSUN2, and ELP3) in breast cancer samples with different subtypes, grades, and NPIs. (A) Expression levels of three RNMTs across five subtypes of TCGA breast cancer samples. (B) Expression levels of three RNMTs in three grades of METABRIC breast cancer samples. (C) Expression levels of three RNMTs in METABRIC patients with poor prognosis (NPI > 3.4) and good prognosis (NPI ≤ 3.4) scores. High expressions of FTSJ3 and NSUN2, but lower expression of ELP3, were significantly (p < 0.001) associated with higher grade and NPI score of METABRIC breast cancers.